CHINA : The World Health Organization (WHO) has found that the corona vaccine, developed by China’s Sinovac Biotech, is effective in preventing corona infections in adults under the age of 60.
However, they noted that accurate conclusions about the risk of serious adverse effects from the vaccine have not yet been obtained.
Independent experts from the World Health Organization’s Strategic Advisory Council have been conducting studies on Sinovac from phases of clinical trials in China, Brazil, Indonesia, Turkey and Chile.
Meanwhile, Sinopharm, a Chinese state-owned pharmaceutical company, has also released information on the risk of serious side effects for some corona patients.
Meanwhile, the synovial vaccine has been approved by 32 countries under domestic jurisdiction and 260 million vaccines have been distributed, experts said.Leave a comment